2015 - 2018 Establishment of diagnostic procedure and the new diagnostic criteria of mitochondrial cardiomyopathy based on an Imaging technology
Papers (56):
Abe J, Vujic A, Prag HA, Murphy MP, Thomas Krieg. Malonate given at reperfusion prevents post-myocardial infarction heart failure by decreasing ischemia/reperfusion injury. Basic research in cardiology. 2024
Jiro Abe, Nasu T, Noro A, Tsubaki J. An unusual case of severe asphyxia with the fetal position unexpectedly inverted in a malformed uterus: a case report. Journal of medical case reports. 2024
Jiro Abe, Junko Tsubaki, Kazuhiro Shimura, Tomonobu Hasegawa. A Pitfall of Adrenal Hypoplasia Congenita. Clinical pediatrics. 2024. 99228231222714-99228231222714
Yuji Maruo, Masahiro Shiraishi, Mitsue Hibino, Jiro Abe, Atsuhito Takeda, Yuma Yamada. Activation of Mitochondria in Mesenchymal Stem Cells by Mitochondrial Delivery of Coenzyme Q10. Biological & pharmaceutical bulletin. 2024. 47. 8. 1415-1421
Jiro Abe, Masahiro Ueki, Ryota Honjou, Kenta Takeda, Yoshitaka Seto, Yuichi Nakamura, Yuta Furuse, Koh Nakata, Kazutoshi Cho. The clinical importance of pulmonary gene and protein expression levels in an infant with lethal ABCA3 variants. Pediatric Pulmonology. 2023. 58. 10. 2956-2959
Abe Jiro, Murphy Mike, Krieg Thomas. Inhibiting Reverse Electron Transport at Reperfusion with Malonate Prevents the Consequential Heart Failure(タイトル和訳中). 日本循環器学会学術集会抄録集. 2024. 88回. OE30-7
2022 - 2024 University of Cambridge Mitochondria Biology Unit Medical Research Council Mitochondria Dysfunction Group and Clinical Medicine
2013 - 2017 Hokkaido University Graduate School of Medicine
Work history (2):
2024/04 - 現在 北海道大学薬学研究院 薬剤分子設計学研究室 客員研究員
2024/01 - 現在 Graduate School of Medicine Hokkaido University Department of Pediatrics Senior doctor
Awards (4):
2019 - Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering Overseas research fellowship
2018 - European Paediatric and Congenital Cardiology, the 52nd Annual Meeting of the Association YIA winner An innovative cell therapy using mitochondrial drug delivery system for doxorubicin cardiomyopathy
2018 - Miyata Foundation Award for Young Scientists
2017 - The 39th Cardiac Biopsy Conference Young Investigator Award Stem cells with mitochondrial drug delivery system can ameliorate survival of doxorubicin-induced cardiomyopathy.
Association Membership(s) (6):
American Heart Association
, European Society of Cardiology
, Japanese Society of Mitochondia Research and Medicine
, Japanese Circulation Society
, Japanese Society of Pediatric Cardiology and Cardiac Surgery
, Japanese Pediatric Society